CRS: BJMC
Position: Community Coordinator
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...
An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...
Study Objective: Compare longitudinal HIV-1 antibody responses among HIV-1 infected participants that either did or did not...
The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
